drugset / Trial / NCT07054398

Assessment of Serum Catestatin Level in Acne Vulgaris Patients

NCT07054398

Recruiting 60 enrolled Aswan University
RandomizedParallel-groupOpen-labelTreatment

Summary

Acne vulgaris is a persistent inflammatory condition of the pilosebaceous unit, affecting 85% of people between the ages of 12 and 24, it is regarded as one of the most common diseases in teenagers and young adults. Catestatin, a peptide derived from chromogranin A (CgA), was first discovered in 1997 as an acute nicotinic-cholinergic antagonist. Later, it was determined that CST is a pleiotropic hormone.

Timeline

Start
2025-01-10
Primary completion
2026-01-01
Completion
2026-01-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Isotretinoin Other / unclassified Oral

Indications